SK1062001A3 - Isoquinolines as urokinase inhibitors - Google Patents

Isoquinolines as urokinase inhibitors Download PDF

Info

Publication number
SK1062001A3
SK1062001A3 SK106-2001A SK1062001A SK1062001A3 SK 1062001 A3 SK1062001 A3 SK 1062001A3 SK 1062001 A SK1062001 A SK 1062001A SK 1062001 A3 SK1062001 A3 SK 1062001A3
Authority
SK
Slovakia
Prior art keywords
chloro
isoquinolyl
mmol
guanidine
sulfonyl
Prior art date
Application number
SK106-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Christopher Gordon Barber
Roger Peter Dickinson
Paul Vincent Fish
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/IB1999/001289 external-priority patent/WO2000005214A2/en
Publication of SK1062001A3 publication Critical patent/SK1062001A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SK106-2001A 1998-07-24 1999-07-15 Isoquinolines as urokinase inhibitors SK1062001A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9816228.2A GB9816228D0 (en) 1998-07-24 1998-07-24 Isoquinolines
GBGB9908829.6A GB9908829D0 (en) 1998-07-24 1999-04-16 Isoquinolines
PCT/IB1999/001289 WO2000005214A2 (en) 1998-07-24 1999-07-15 Isoquinolines as urokinase inhibitors

Publications (1)

Publication Number Publication Date
SK1062001A3 true SK1062001A3 (en) 2001-11-06

Family

ID=10836172

Family Applications (1)

Application Number Title Priority Date Filing Date
SK106-2001A SK1062001A3 (en) 1998-07-24 1999-07-15 Isoquinolines as urokinase inhibitors

Country Status (39)

Country Link
EP (1) EP1077945B1 (es)
JP (1) JP2002521367A (es)
KR (1) KR20010083137A (es)
CN (1) CN1318059A (es)
AR (1) AR018960A1 (es)
AT (1) ATE230730T1 (es)
AU (1) AU745545B2 (es)
BG (1) BG105252A (es)
BR (1) BR9912374A (es)
CA (1) CA2337247A1 (es)
CO (1) CO5080787A1 (es)
DE (1) DE69904814T2 (es)
DK (1) DK1077945T3 (es)
DZ (1) DZ2852A1 (es)
EA (1) EA200100073A1 (es)
EE (1) EE200100049A (es)
ES (1) ES2189434T3 (es)
GB (2) GB9816228D0 (es)
GT (1) GT199900116A (es)
HK (1) HK1040996A1 (es)
HN (1) HN1999000116A (es)
HR (1) HRP20010059A2 (es)
HU (1) HUP0103665A3 (es)
ID (1) ID26993A (es)
IS (1) IS5789A (es)
MA (1) MA26664A1 (es)
NO (1) NO20010400L (es)
OA (1) OA11578A (es)
PA (1) PA8478901A1 (es)
PE (1) PE20000937A1 (es)
PL (1) PL346022A1 (es)
PT (1) PT1077945E (es)
SI (1) SI1077945T1 (es)
SK (1) SK1062001A3 (es)
TN (1) TNSN99149A1 (es)
TR (1) TR200100222T2 (es)
TW (1) TW530049B (es)
UY (1) UY25663A1 (es)
ZA (1) ZA200100230B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE399175T1 (de) * 2002-03-11 2008-07-15 Curacyte Ag Hemmstoffe der urokinase, ihre herstellung und verwendung
DE602004020657D1 (de) 2003-12-02 2009-05-28 Sanol Arznei Schwarz Gmbh Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
EP1604655A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in trigeminal neuralgia
EP1604656A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
EP2462990B2 (en) 2006-06-15 2018-04-18 UCB Pharma GmbH Pharmaceutical composition comprising lacosamide and levetiracetam with synergistic anticonvulsant effect

Also Published As

Publication number Publication date
AR018960A1 (es) 2001-12-12
TNSN99149A1 (fr) 2005-11-10
EP1077945A1 (en) 2001-02-28
NO20010400D0 (no) 2001-01-23
DZ2852A1 (fr) 2003-12-01
PE20000937A1 (es) 2000-09-18
PL346022A1 (en) 2002-01-14
CN1318059A (zh) 2001-10-17
GB9908829D0 (en) 1999-06-16
AU745545B2 (en) 2002-03-21
GT199900116A (es) 2001-01-13
DE69904814T2 (de) 2003-04-30
PA8478901A1 (es) 2000-09-29
ATE230730T1 (de) 2003-01-15
TR200100222T2 (tr) 2001-12-21
JP2002521367A (ja) 2002-07-16
ZA200100230B (en) 2002-03-01
DE69904814D1 (de) 2003-02-13
NO20010400L (no) 2001-03-26
EE200100049A (et) 2002-06-17
HK1040996A1 (zh) 2002-06-28
CA2337247A1 (en) 2000-02-03
EP1077945B1 (en) 2003-01-08
HUP0103665A2 (hu) 2002-02-28
TW530049B (en) 2003-05-01
OA11578A (en) 2004-07-20
UY25663A1 (es) 2000-03-31
HRP20010059A2 (en) 2002-02-28
EA200100073A1 (ru) 2001-10-22
HUP0103665A3 (en) 2002-06-28
CO5080787A1 (es) 2001-09-25
ID26993A (id) 2001-02-22
DK1077945T3 (da) 2003-04-22
PT1077945E (pt) 2003-03-31
IS5789A (is) 2000-12-22
BG105252A (en) 2001-12-29
KR20010083137A (ko) 2001-08-31
GB9816228D0 (en) 1998-09-23
AU4528999A (en) 2000-02-14
ES2189434T3 (es) 2003-07-01
MA26664A1 (fr) 2004-12-20
SI1077945T1 (en) 2003-04-30
BR9912374A (pt) 2001-04-17
HN1999000116A (es) 2000-11-11

Similar Documents

Publication Publication Date Title
AU722384B2 (en) Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
US5648364A (en) Retroviral protease inhibitors
JPH0660144B2 (ja) シクロアルキル置換されたグルタルアミド抗高血圧剤
US6093731A (en) Isoquinolines
JP3521347B2 (ja) 2−ピリジニルグアニジン系ウロキナーゼ阻害薬
EP0927035A1 (en) Thrombin inhibitors
CA2282399A1 (en) Thioaryl sulfonamide hydroxamic acid compounds
RU2327688C2 (ru) Основные непептидные антагонисты брадикинина и их фармацевтические композиции
JP3600794B2 (ja) ウロキナーゼ阻害薬としてのイソキノリン類
JP2000503010A (ja) アミジノプロテアーゼ阻害剤
AU2277699A (en) Matrix metalloprotease inhibitors
SK1062001A3 (en) Isoquinolines as urokinase inhibitors
KR100668194B1 (ko) 아미노산 유도체, 이의 제조 방법 및 이를 포함하는 약제조성물
MXPA00004241A (es) Nuevos compuestos de 2,3-metano-amino acido, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
CZ2001289A3 (cs) Isochinoliny jako inhibitory urokinasy
MXPA01000888A (es) Isoquinolinas
MXPA99011261A (es) Derivados de fenilalquilo, composiciones farmaceuticas que contienen estos compuestos y procesospara prepararlos
MXPA97009386A (es) Derivados del arilsulfonilaminobenceno y el uso de los mismos como inhibidores del factor xa
MXPA00003589A (es) Inhibidores de uroquinasa de 2-piridinilguanidina